Active actinium

Deblonde, Gauthier J. -P.; Abergel, Rebecca J.

doi:10.1038/nchem.2653

Title: Active actinium

Abstract

Naturally scarce but synthetically accessible, Gauthier J.-P. Deblonde and Rebecca J. Abergel discuss element 89 and its emergence as a candidate radio-theranostic metal for cancer treatment.

Authors:

Deblonde, Gauthier J. -P. ^[1]; Abergel, Rebecca J. ^[1]

Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Chemical Sciences Division

Publication Date:: Fri Oct 21 00:00:00 EDT 2016

Research Org.:: Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)

Sponsoring Org.:: USDOE Office of Science (SC), Basic Energy Sciences (BES). Chemical Sciences, Geosciences, and Biosciences Division

OSTI Identifier:: 1458479

Grant/Contract Number:: AC02-05CH11231

Resource Type:: Accepted Manuscript

Journal Name:: Nature Chemistry

Additional Journal Information:: Journal Volume: 8; Journal Issue: 11; Journal ID: ISSN 1755-4330

Publisher:: Nature Publishing Group

Country of Publication:: United States

Language:: English

Subject:: 62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats


                    Deblonde, Gauthier J. -P., and Abergel, Rebecca J. Active actinium.  United States: N. p., 2016. 
Web.  doi:10.1038/nchem.2653.

Copy to clipboard


                    Deblonde, Gauthier J. -P., & Abergel, Rebecca J. Active actinium.  United States.  https://doi.org/10.1038/nchem.2653

Copy to clipboard


                    Deblonde, Gauthier J. -P., and Abergel, Rebecca J. Fri .  
"Active actinium".  United States.  https://doi.org/10.1038/nchem.2653.  https://www.osti.gov/servlets/purl/1458479.

Copy to clipboard


                    
@article{osti_1458479,

  title        = {Active actinium},

  author       = {Deblonde, Gauthier J. -P. and Abergel, Rebecca J.},

  abstractNote = {Naturally scarce but synthetically accessible, Gauthier J.-P. Deblonde and Rebecca J. Abergel discuss element 89 and its emergence as a candidate radio-theranostic metal for cancer treatment.},

  doi          = {10.1038/nchem.2653},

  journal      = {Nature Chemistry},

  number       = 11,

  volume       = 8,

  place        = {United States},

  year         = {Fri Oct 21 00:00:00 EDT 2016},

  month        = {Fri Oct 21 00:00:00 EDT 2016}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (DOE)

Publisher's Version of Record

https://doi.org/10.1038/nchem.2653

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 12 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Spectroscopic and computational investigation of actinium coordination chemistry
journal, August 2016

Ferrier, Maryline G.; Batista, Enrique R.; Berg, John M.
Nature Communications, Vol. 7, Issue 1
DOI: 10.1038/ncomms12312

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy
journal, January 2013

McLaughlin, Mark F.; Woodward, Jonathan; Boll, Rose A.
PLoS ONE, Vol. 8, Issue 1
DOI: 10.1371/journal.pone.0054531

Preliminary Therapy Evaluation of ²²⁵ Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from ²²⁵ Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization
journal, January 2016

Pandya, Darpan N.; Hantgan, Roy; Budzevich, Mikalai M.
Theranostics, Vol. 6, Issue 5
DOI: 10.7150/thno.14338

Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
journal, September 2008

Miederer, Matthias; Scheinberg, David A.; McDevitt, Michael R.
Advanced Drug Delivery Reviews, Vol. 60, Issue 12
DOI: 10.1016/j.addr.2008.04.009

Works referencing / citing this record:

Structure and properties of DOTA-chelated radiopharmaceuticals within the ²²⁵ Ac decay pathway
journal, January 2018

Khabibullin, Artem R.; Karolak, Aleksandra; Budzevich, Mikalai M.
MedChemComm, Vol. 9, Issue 7
DOI: 10.1039/c8md00170g

Similar Records in DOE PAGES and OSTI.GOV collections:

Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control

Journal Article Evans, Michael A. ; Huang, Po-Ju ; Iwamoto, Yuji ; ... - Chemical Science

Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia, if its concentration and localization can be precisely controlled. Here, we report a "Trojan Horse" strategy to provide the necessary spatial, temporal, and dosage control of such drug-delivery therapies at targeted tissues. Described is a unique package consisting of (1) a manganese-nitrosyl complex, which is a photoactivated NO-releasing moiety (photoNORM), plus Nd³⁺-doped upconverting nanoparticles (Nd-UCNPs) incorporated into (2) biodegradable polymer microparticles that are taken up by (3) bone-marrow derived murine macrophages. Both the photoNORM [Mn(NO)dpaq^NO₂]BPh₄(dpaq^NO₂ = 2-[N,N-bis(pyridin-2-yl-methyl)]-amino-N'-5-nitro-quinolin-8-yl-acetamido) and the Nd-UCNPs are activated by tissue-penetrating near-infrared (NIR) light atmore »« less
Cited by 56
https://doi.org/10.1039/C8SC00015H
Curious curium

Journal Article Abergel, Rebecca J. ; Ansoborlo, Eric - Nature Chemistry

From secretive beginnings to serving in missions on Mars, Rebecca J. Abergel and Eric Ansoborlo take a look at the glowing mark curium has left on contemporary science and technology.
Cited by 12
https://doi.org/10.1038/nchem.2512

Full Text Available
The coordination properties and ionic radius of actinium: A 120-year-old enigma

Journal Article Deblonde, Gauthier J.-P. ; Zavarin, Mavrik ; Kersting, Annie B. - Coordination Chemistry Reviews

Actinium is an elusive element with untamed properties and represents a peculiar case in the periodic table, as its isotopes are all radioactive, the longest-lived one having only a 22-year half-life, and the availability of actinium isotopes remains very low (microgram level, at best), hindering research on its compounds. Despite being a natural element discovered more than 120 years ago, and despite an increasing interest in using one of its isotopes (²²⁵Ac) for highly efficient cancer therapies, the chemistry of actinium is still largely unknown relative to other elements. Since Ac is the first element of the actinide series, itmore »« less
https://doi.org/10.1016/j.ccr.2021.214130

Full Text Available
Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

Journal Article Meier, Jason P. ; Zhang, Hannah J. ; Freifelder, Richard ; ... - Molecules

In the field of nuclear medicine, the β⁺ -emitting ⁴³Sc and β^- -emitting ⁴⁷Sc are promising candidates in cancer diagnosis and targeted radionuclide therapy (TRT) due to their favorable decay schema and shared pharmacokinetics as a true theranostic pair. Additionally, scandium is a group-3 transition metal (like ¹⁷⁷Lu) and exhibits affinity for DOTA-based chelators, which have been studied in depth, making the barrier to implementation lower for ^43/47Sc than for other proposed true theranostics. Before ^43/47Sc can see widespread pre-clinical evaluation, however, an accessible production methodology must be established and each isotope’s radiolabeling and animal imaging capabilities studied with amore »« less
https://doi.org/10.3390/molecules28166041

Full Text Available
WE-FG-BRA-11: Theranostic Platinum Nanoparticle for Radiation Sensitization in Breast Cancer Radiotherapy

Journal Article Yue, Y ; Wagner, S ; Medina-Kauwe, L ; ... - Medical Physics

Purpose: We have developed a novel receptor-targeted theranostic platinum nanoparticle (HER-PtNP) for enhanced radiation sensitization in HER2-positive breast cancer radiation treatment. This study aims to evaluate receptor-targeting specificity, and radiation sensitization of the nanoparticle. Methods: The platinum nanoparticle (PtNP) was synthesized with the diameter of 2nm, and capped with cysteine. The nanoparticle was tagged with a fluorescent dye (cy5) for the fluoresence detection, and conjuated with HER2/3 targeted protein (HerPBK10) for HER2-targeting specificity. We evaluated the theranostic features using in vitro breast cancer cell models: HER2-positive BT-474, and HER2-negative MDA-MB-231. The HER2-targeting specificity was evaluated using immunofluorescence and confocal microscopy.more »« less
https://doi.org/10.1118/1.4957911

Similar Records

Title: Active actinium

Abstract

Citation Formats

Spectroscopic and computational investigation of actinium coordination chemistry journal, August 2016

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy journal, January 2013

Preliminary Therapy Evaluation of 225 Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from 225 Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization journal, January 2016

Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications journal, September 2008

Structure and properties of DOTA-chelated radiopharmaceuticals within the 225 Ac decay pathway journal, January 2018

Spectroscopic and computational investigation of actinium coordination chemistry
journal, August 2016

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy
journal, January 2013

Preliminary Therapy Evaluation of ²²⁵ Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from ²²⁵ Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization
journal, January 2016

Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
journal, September 2008

Structure and properties of DOTA-chelated radiopharmaceuticals within the ²²⁵ Ac decay pathway
journal, January 2018